Read about Recursive’s Flint AI coding model, its laptop-friendly design, coding benchmarks, open-source license, and Eureka ...
On October 9, 2026, Google's research team (Google Cloud AI Research) and Northwestern University posted the "Harness²" paper ...
AI can write code that runs. CS coursework tests whether you understand it. Here's where AI code fails and how to check it ...
When studying programming, you notice something strange.Processes that are extremely complex for humans to think through can ...
See how modern search utilities add fuzzy matching, context highlights, and configurable result pipelines for speed.
“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...
How do you get from a chatbot that sometimes makes things up to a machine that humans might struggle to control? There are several steps in that argument, and plenty of uncertainty. But an idea known ...
Recursive self-improvement could, in theory, lead to superintelligent AI. That is the short answer. The harder answer is that today's systems only show bounded, supervised self-refinement, not a ...
AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...
Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...